Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients

  • B.S. Kappelhoff
  • , A.D.R. Huitema
  • , K.M.L. Crommentuyn
  • , J.W. Mulder
  • , P.L. Meenhorst
  • , E.C.M van Gorp
  • , A.T.A. Mairuhu
  • , J.H. Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)174-182
Number of pages9
JournalBritish Journal of Clinical Pharmacology
Volume59
Issue number2
Publication statusPublished - 2005

Cite this